Zhang Jingyu, Tian Xiao-Jun, Xing Jianhua
Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA.
J Clin Med. 2016 Mar 28;5(4):41. doi: 10.3390/jcm5040041.
Epithelial-to-mesenchymal transition (EMT) is a key step in development, wound healing, and cancer development. It involves cooperation of signaling pathways, such as transformation growth factor-β (TGF-β), Sonic Hedgehog (SHH), and WNT pathways. These signaling pathways crosstalk to each other and converge to key transcription factors (e.g., SNAIL1) to initialize and maintain the process of EMT. The functional roles of multi-signaling pathway crosstalks in EMT are sophisticated and, thus, remain to be explored. In this review, we focused on three major signal transduction pathways that promote or regulate EMT in carcinoma. We discussed the network structures, and provided a brief overview of the current therapy strategies and drug development targeted to these three signal transduction pathways. Finally, we highlighted systems biology approaches that can accelerate the process of deconstructing complex networks and drug discovery.
上皮-间质转化(EMT)是发育、伤口愈合和癌症发展过程中的关键步骤。它涉及多种信号通路的协同作用,如转化生长因子-β(TGF-β)、音猬因子(SHH)和WNT通路。这些信号通路相互作用并汇聚到关键转录因子(如SNAIL1)以启动和维持EMT过程。多信号通路相互作用在EMT中的功能作用复杂,因此仍有待探索。在本综述中,我们重点关注了在癌中促进或调节EMT的三种主要信号转导通路。我们讨论了网络结构,并简要概述了针对这三种信号转导通路的当前治疗策略和药物开发情况。最后,我们强调了系统生物学方法,这些方法可以加速解构复杂网络和药物发现的进程。